Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantation

Bone Marrow Transplant. 2024 Aug;59(8):1193-1195. doi: 10.1038/s41409-024-02315-1. Epub 2024 May 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acetates* / therapeutic use
  • Adolescent
  • Allografts
  • Antiviral Agents / therapeutic use
  • Child
  • Child, Preschool
  • Cytomegalovirus
  • Cytomegalovirus Infections* / etiology
  • Cytomegalovirus Infections* / prevention & control
  • Female
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Infant
  • Male
  • Quinazolines* / therapeutic use
  • Transplantation, Homologous

Substances

  • letermovir
  • Acetates
  • Quinazolines
  • Antiviral Agents